









Markets
/
Stocks
/
nasdaq-rnam
/

Avidity Biosciences Ord Shs

RNAM

72.860

0.0000.00%

Close 03/03, 16:00（ET）Quotes delayed by 15 min

--Market Cap

--P/E TTM



Avidity Biosciences Ord Shs

72.860

0.0000.00%

Overview Financials Analysis Company

Overview

Financials

Analysis

Company

You can check out the annual or quarterly balance sheets of Avidity Biosciences Ord Shs here to evaluate the financial health, analyze fundamentals, and calculate key ratios for liquidity, leverage, and return on equity.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2025Q4

Total equity

Cash, cash equivalents and short-term investments

--1.70B

- Cash and cash equivalents

--382.52M

-Short-term investments

--1.31B

Receivables

--12.44M

-Loans receivable

--12.44M

Prepaid expenses

--36.46M

Other current assets

--52.70M

Total current assets

--1.80B

Non-current assets

Net Fixed Assets

--74.61M

-Fixed Assets

--86.39M

-Accumulated depreciation

--11.78M

Other non-current assets

--84.97M

Total non-current assets

--159.58M

Total assets

--1.96B

Liabilities

Current liabilities

Accrued expenses

--157.47M

Deferred liabilities

--21.64M

Other current liabilities

--21.64M

Total current liabilities

--195.45M

Non-current liabilities

Long-term debt and lease liabilities

--45.31M

-Long-term lease liabilities

--45.31M

Deferred liabilities

--28.69M

Other non-current liabilities

--28.69M

Total non-current liabilities

--74.00M

Total liabilities

--269.45M

Shareholders' equity

Common equity

--3.26B

Retained earnings

---1.58B

Capital reserves

--3.26B

Gains losses not affecting retained earnings

--2.56M

Total equity

--1.69B

Currency unit

USD

Audit opinions

FAQs

What is the balance sheet?



It is a financial report that summarises the assets, liabilities, and shareholders’ equity of a company at a specific point in time.

KeyAI

